In 2023, the antihypertensive medicine sales in Italy stood at a certain baseline per capita level, on which future forecasts depend. The predictive data from 2024 reveals a gradual decline in sales, with per capita values projected to decrease from 2.9 in 2024 to 2.4 by 2028.

Key observations from the forecasted trend include:

A year-on-year decrease is anticipated, with a projected 6.9% decline from 2024 to 2028.
The Compound Annual Growth Rate (CAGR) for 2024-2028 indicates an average decline of 5% per annum.

Future trends to watch for include developments in healthcare policies, lifestyle changes that may affect the prevalence of hypertension, and breakthroughs in alternative treatments that could impact pharmaceutical demand.

Download as XLS

More about Antihypertensive Industry 2025-2029